武汉云克隆科技股份有限公司

脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Phospholipase A2 Group VII (LpPLA2)

PLA2G7; PAF-AH; PAFAH; Lp-PLA2; LDL-PLA2; Platelet Activating Factor Acetylhydrolase,Plasma; Phospholipase A2,Group VII; LDL-associated phospholipase A2; Phospholipase A2, Lipoprotein Associated

  • 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法)实验结果图
  • SEA867Ra.jpg标准曲线图
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测脂蛋白关联磷脂酶A2(LpPLA2)，经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制，不可能完成对所有相关或相似物质交叉反应检测，因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的脂蛋白关联磷脂酶A2(LpPLA2)（加标样品），重复测定并计算其均值，回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)79-9591
EDTA plasma(n=5)91-10196
heparin plasma(n=5)82-9987

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差：取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次，分别计算不同浓度样本的平均值及SD值。
批间差：选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定，每个样本使用同一试剂盒重复测定8次，分别计算不同浓度样本的平均值及SD值。
批内差： CV<10%
批间差： CV<12%

线性

在定值血清及血浆样本内加入适量的脂蛋白关联磷脂酶A2(LpPLA2)，并倍比稀释成1:2，1:4，1:8，1:16的待测样本，线性范围即为稀释后样本中脂蛋白关联磷脂酶A2(LpPLA2)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)96-105%91-99%91-103%95-102%
EDTA plasma(n=5)79-104%88-102%86-98%99-105%
heparin plasma(n=5)89-96%84-98%94-102%78-90%

稳定性

经测定，试剂盒在有效期内按推荐温度保存，其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响，实验室的环境条件需尽量保持一致，尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备；
2. 加样（标准品及样本）100µL，37°C孵育1小时；
3. 吸弃，加检测溶液A100µL，37°C孵育1小时；
4. 洗板3次；
5. 加检测溶液B100µL，37°C孵育30分钟；
6. 洗板5次；
7. 加TMB底物90µL，37°C孵育10-20分钟；
8. 加终止液50µL，立即450nm读数。

实验原理

将脂蛋白关联磷脂酶A2(LpPLA2)抗体包被于96孔微孔板中，制成固相载体，向微孔中分别加入标准品或标本，其中的脂蛋白关联磷脂酶A2(LpPLA2)与连接于固相载体上的抗体结合，然后加入生物素化的脂蛋白关联磷脂酶A2(LpPLA2)抗体，将未结合的生物素化抗体洗净后，加入HRP标记的亲和素，再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色，并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的脂蛋白关联磷脂酶A2(LpPLA2)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值)，计算样品浓度。

相关产品

编号适用物种：Rattus norvegicus (Rat，大鼠)应用(仅供研究使用，不用于临床诊断！)
APA867Ra61脂蛋白关联磷脂酶A2(LpPLA2)活性蛋白Cell culture; Activity Assays.
EPA867Ra61脂蛋白关联磷脂酶A2(LpPLA2)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA867Ra01脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA867Ra01脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体WB; IHC; ICC; IP.
SEA867Ra脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA867Ra脂蛋白关联磷脂酶A2(LpPLA2)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Science & SportsThe effects of different intensity walking programs on serum blood lipids, high-sensitive C-reactive protein, and lipoprotein-associated phospholipase A2 in premenopausal women[ScienceDirect: S0765159710000262]
Metabolic Syndrome and Related DisordersAssociation of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease[Wiley: source]
34Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study[PubMed: 22240497]
PLoS ONEEffects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo[PubMed: PMC3759413]
China PharmacyInfluence of Tongfengtai Granules on Inflammatory Factor in Acute Gouty Arthritis Model Rats[Source]
AtherosclerosisEverolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients.[Pubmed: 23958269]
Journal of Diabetes ResearchLipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus[Hindawi: 278063]
HealthThe Role of Asymmetric Dimethylarginine and Lipoprotein Associated Phospholipase A2 in Children and Adolescents with Dyslipidemia[Scirp:Source]
Biology BulletinIn vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood[Springer:Source]
Gynecol Endocrinol. Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus.[Pubmed:24397392]
Journal of Diabetes ResearchLipoprotein-Associated Phospholipase A 2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus[Pubmed:24818163]
Metabolism.Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes[Pubmed:25034387]
J Am Heart AssocEffect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients[PubMed: 26374297]
Czecho-Slovak Dermatology / Cesko-Slovenska DermatologieV[Ebscohost]
Endocrinol Metab (Seoul).Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA2 in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome[pmc:PMC4803547]
Clin Pharmacol Ther. Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery[Pubmed:25773594]
Lipids in Health and DiseaseEffect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A 2 and secretory phospholipase A 2 in patients with newly …[articles:10.1186]
Acta EndocrinologicaSERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA.[jrnl:1841098]
Biomarker for diagnosis of moyamoya disease[:]
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATIONCirculating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions[Pubmed: 32859455]
chinese neurosurgical journalCan admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage?[]